158 related articles for article (PubMed ID: 3539124)
21. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
Khan NW; Hassan F; Naqvi BS; Hasan SM
Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
[TBL] [Abstract][Full Text] [Related]
22. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
24. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
Ekşi F; Ozer G; Balci I
Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
[TBL] [Abstract][Full Text] [Related]
25. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
Piantieri G; Cafarelli A; Magliulo E
G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
[No Abstract] [Full Text] [Related]
26. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
27. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
28. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
29. Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.
Yanyali A; Cetin S; Talu H; Vahaboglu H
Ophthalmologica; 2001; 215(6):439-43. PubMed ID: 11741112
[TBL] [Abstract][Full Text] [Related]
30. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli in Granada, Spain.
Sorlózano A; Gutiérrez J; Salmerón A; Luna JD; Martínez-Checa F; Román J; Piédrola G
Int J Antimicrob Agents; 2006 Dec; 28(6):532-6. PubMed ID: 17045785
[TBL] [Abstract][Full Text] [Related]
31. In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.
Yourassowsky E; Schoutens E; Van der Linden MP; Lismont MJ
Infection; 1979; 7(5):237-9. PubMed ID: 389805
[TBL] [Abstract][Full Text] [Related]
32. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
Saionji K
Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
Melby K; Midtvedt T; Dahl O
Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
[TBL] [Abstract][Full Text] [Related]
34. Alteration of effectiveness of antibiotics by anaerobiosis.
Verklin RM; Mandell GL
J Lab Clin Med; 1977 Jan; 89(1):65-71. PubMed ID: 318675
[TBL] [Abstract][Full Text] [Related]
35. [In vitro effect of combinations of daunorubicin and antibiotics against various bacterial strains].
Fourche J; Maugein J; Pellegrin JL; Mormede M
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):591-4. PubMed ID: 2677927
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the so-called basic cephalosporins using the serum bactericidal test].
Milatovic D; Voss A; Machka K; Braveny I
Med Klin (Munich); 1992 Feb; 87(2):58-62. PubMed ID: 1542283
[TBL] [Abstract][Full Text] [Related]
37. [In-vitro effect of tobramycin].
Jedlicková Z
Z Arztl Fortbild (Jena); 1977 Jul; 71(13):651-2. PubMed ID: 412333
[No Abstract] [Full Text] [Related]
38. [New cephalosporin antibiotic: cephapirin].
Urbinati G
Clin Ter; 1977 Mar; 80(5):491-9. PubMed ID: 322931
[No Abstract] [Full Text] [Related]
39. Bactericidal activity of cefazedone.
Dingeldein E
Arzneimittelforschung; 1979; 29(2a):394-6. PubMed ID: 385008
[TBL] [Abstract][Full Text] [Related]
40. The influence of cefepime on opsonophagocytosis of bacteria.
Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
